Stelara biosimilar from Alvotech, Teva approved by FDA
Bio Pharma Dive
APRIL 17, 2024
The companies plan to launch their copycat version of the blockbuster immune disease drug early next year, per a legal settlement with J&J.
Wed.Apr 17, 2024
300 
Lexeo wins fast track designation for Friedreich’s ataxia gene therapy
Pharmaceutical Technology
APRIL 17, 2024
LX2006 consists of adeno-associated virus (AAV) vector carrying the frataxin gene, responsible for causing Friedreich’s ataxia.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sage’s cognition drug fails in Parkinson’s study
Bio Pharma Dive
APRIL 17, 2024
Following negative results, the company doesn’t plan to further test SAGE-718 in Parkinson’s. Other studies in Huntington’s and Alzheimer’s remain ongoing.
April 17, 2024: In This Week’s PCT Grand Rounds, 10 Years of the YODA Project
Rethinking Clinical Trials
APRIL 17, 2024
Dr. Joseph Ross In this Friday’s PCT Grand Rounds, Joseph Ross of Yale University will present “The Yale Open Data Access (YODA) Project: 10 Years of Clinical Trial Data Sharing.” The Grand Rounds session will be held on Friday, April 19, 2024, at 1:00 pm eastern. The YODA Project promotes open science, research transparency, and the sharing of clinical research data to support healthcare research.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Lilly obesity drug shows benefit in sleep disorder study, pointing to new use
Bio Pharma Dive
APRIL 17, 2024
Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Fierce Pharma
APRIL 17, 2024
One-year data continued to support a more convenient, injectable version of Roche’s blockbuster multiple sclerosis (MS) drug Ocrevus ahead of an FDA decision, the Swiss pharma said. | One-year data continued to support a more convenient, injectable version of Roche’s blockbuster multiple sclerosis drug Ocrevus ahead of an FDA decision, the Swiss pharma said.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
TAE Life Sciences Welcomes Dr. Deepak “Dee” Khuntia to Its Board of Directors
Pharma Mirror
APRIL 17, 2024
As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE Life Sciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces the appointment of Dr. Deepak “Dee” Khuntia, M.D., FASTRO, to its esteemed Board of Directors.
IGM and Sanofi collaboration will pivot to immunology and inflammation
Pharmaceutical Technology
APRIL 17, 2024
The deal will now see IGM doubling down on IgM antibody development for immunology and inflammation targets.
Study reveals how specific nasal cells protect against COVID-19 in paediatric patients
Pharma Times
APRIL 17, 2024
The findings suggest why children tend to experience milder symptoms compared to older adults
WuXi AppTec gets grant for process for preparing dichloroacetic acid composition with low glyoxylic acid
Pharmaceutical Technology
APRIL 17, 2024
Discover the innovative patent by WuXi AppTec Co Ltd for preparing a dichloroacetic acid composition with minimal glyoxylic acid. Learn about the process and benefits of accurate glyoxylic acid measurement.
AI in Medical Communications: Revolutionising the present, redefining the future
pharmaphorum
APRIL 17, 2024
Discover how AI is transforming medical communications and reshaping the future of healthcare. Learn about the latest trends, technologies, and advancements in this rapidly evolving field.
TCR2 Therapeutics gets grant for recombinant nucleic acid encoding TCR fusion protein for cancer treatment
Pharmaceutical Technology
APRIL 17, 2024
Discover the groundbreaking patent by TCR2 Therapeutics Inc for T-cell receptor fusion proteins targeting tumor cell antigens. Revolutionizing disease treatment, including cancer, with engineered T cells expressing TFPs.
Eli Lilly's tirzepatide scores again, this time in 2 sleep apnea trials
Fierce Pharma
APRIL 17, 2024
In addition to their acclaimed efficacy against diabetes and obesity, GLP-1 drugs are gaining traction for their potential to treat a variety of other common disorders. | In addition to their acclaimed efficacy against diabetes and obesity, GLP-1 drugs are gaining traction for their potential to treat a variety of other common disorders. Now, two trials have shown that Eli Lilly’s weight loss product Zepbound (tirzepatide) can help patients overcome obstructive sleep apnea (OSA).
Kaleido Biosciences gets grant for glycan therapeutic preparation for reducing gastrointestinal inflammation in immune imbalance
Pharmaceutical Technology
APRIL 17, 2024
Discover how Kaleido Biosciences Inc's patented method using glycan therapeutics can reduce inflammation in gastrointestinal diseases with immune imbalances, offering new treatment options.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Reshoring the UK pharmaceutical supply chain for future resilience
pharmaphorum
APRIL 17, 2024
Learn about the importance of reshoring the UK pharmaceutical supply chain for future resilience. Discover how this strategic move can enhance local production and secure the availability of critical medications.
Unity Biotechnology gets grant for senolytic agents for treating age-related eye conditions
Pharmaceutical Technology
APRIL 17, 2024
Discover Unity Biotechnology's groundbreaking method using small molecule drugs to target senescent cells in the eye, reversing age-related conditions. A newly granted patent reveals a unique approach to promoting vascular repair in the eye, offering hope for those with ophthalmic conditions.
Reuters Pharma Europe 2024 – Day Three
pharmaphorum
APRIL 17, 2024
As Reuters Pharma Europe 2024 comes to a close in Barcelona, pharmaphorum remains on site to live blog the last remaining talks and insights.
ORIC Pharmaceuticals gets grant for PLK4 inhibitors for treating cancer
Pharmaceutical Technology
APRIL 17, 2024
Discover how ORIC Pharmaceuticals Inc's patent for PLK4 inhibitors could revolutionize cancer treatment. Learn about the compound's potential and pharmaceutical applications.
Telehealth firm Cerebral faces $7m FTC fine over privacy
pharmaphorum
APRIL 17, 2024
The FTC is seeking a $7 million fine on telehealth company Cerebral for violating patients' data privacy and making cancellation difficult.
Corvus Pharmaceuticals gets grant for modulating interleukin-2-inducible T-cell kinase
Pharmaceutical Technology
APRIL 17, 2024
Discover the groundbreaking patent by Corvus Pharmaceuticals Inc for treating T-cell lymphoma with specific compounds and compositions. Improve outcomes for patients with cutaneous and peripheral T-cell lymphoma.
ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
Pharma Times
APRIL 17, 2024
Both companies will facilitate career progression while advancing the life sciences industry
Decibel Therapeutics gets grant for hypertonic pharmaceutical composition for anti-platinum chemoprotection
Pharmaceutical Technology
APRIL 17, 2024
Discover the groundbreaking patent by Decibel Therapeutics Inc for hypertonic pharmaceutical compositions with anti-platinum agents to prevent ototoxicity. Learn about the innovative methods and components involved.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Sage drops dalzanemdor for Parkinson’s after trial flop
pharmaphorum
APRIL 17, 2024
Sage Therapeutics has suffered another disappointment after deciding that it will have to drop the Parkinson’s programme for key pipeline drug dalzanemdor after it showed no benefit in a phase 2 trial. The oral positive allosteric modulator (PAM) of the NMDA receptor is being investigated to see if it can counteract mild cognitive impairment in neurodegenerative disorders, and the PRECEDENT trial in Parkinson’s is the first major readout from the drug programme.
Gritstone Bio gets grant for method of identifying cassette sequence for neoantigen vaccine
Pharmaceutical Technology
APRIL 17, 2024
Discover how Gritstone Bio Inc's patented method for designing a neoantigen vaccine cassette sequence enhances effectiveness by minimizing junction epitope risks. Explore the innovative approach outlined in the recently granted patent US11885815B2.
Brexit is ‘driving NHS medicines shortages,’ says report
pharmaphorum
APRIL 17, 2024
Drug shortages fuelled by Brexit are now the 'new normal' in the UK and worsened in 2023, says Nuffield Trust report.
Eagle Pharmaceuticals gets grant for long-term stable bendamustine-containing composition in sterile vial
Pharmaceutical Technology
APRIL 17, 2024
Discover Eagle Pharmaceuticals Inc's patented stable bendamustine-containing composition for long-term storage. Learn about the sterile vial with antioxidants ensuring impurities less than 5% after 15 months.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics – Xtalks Life Science Podcast Ep. 155
XTalks
APRIL 17, 2024
In this episode, Ayesha spoke with Howard Berman, PhD, Founder and CEO of Coya Therapeutics , a clinical-stage biotech company developing regulatory T cell (Treg) therapies targeting neurodegenerative, autoimmune and metabolic diseases. Dr. Berman founded Coya Therapeutics in 2021. Howard Berman, PhD Founder and CEO Coya Therapeutics Dr. Berman has over 18 years of entrepreneurial and industry experience working at the interplay of science and business.
Cultivating Sustainability: How Cloudbyz’s Tree Planting Initiative Transforms Landscapes and Communities
Cloudbyz
APRIL 17, 2024
In today’s world, where environmental concerns are at the forefront of global discussions, the role of businesses in promoting sustainability has never been more crucial. Cloudbyz, a pioneering start-up specializing in Unified eClinical solutions for the healthcare and life sciences industry, stands out as a beacon of environmental responsibility through its innovative sustainability program.
Medincell, AbbVie link up in long-acting injectable development pact worth up to $1.9B
Fierce Pharma
APRIL 17, 2024
After proving the merits of its drug delivery platform last year with the approval of Teva’s long-acting schizophrenia drug Uzedy, France’s Medincell has hooked another big-name partner. | Medincell and AbbVie inked a development and licensing pact to create up to six long-acting injectables, Medincell said Wednesday. Under the deal, Medincell is line to receive an upfront payment of $35 million plus much more in potential development and commercial milestones.
GSK reveals data on novel gonorrhoea drug gepotidacin
pharmaphorum
APRIL 17, 2024
GSK reveals data from EAGLE-1 trial of novel antibiotic gepotidacin for gonorrhoea, amid growing resistance to existing antibiotics.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content